Polymorphism rs1057147 located in mesothelin gene predicts lymph node metastasis in patients with gastric cancer

• Published in: Applied microbiology and biotechnology 2023-06, Vol.107 (11), p.3637-3651
• Main Authors: Shen, Kuan, Cheng, Quan, Xiao, Jian, Zhou, Xinyi, Wang, Yuanhang, Liu, Kanghui, Ni, Peidong, Fan, Hao, Hu, Li, Xu, Zekuan, Yang, Li
• Format: Article
• Language: English
• Subjects: Alleles; Applied Genetics and Molecular Biotechnology; Binding; Bioinformatics; Biomedical and Life Sciences; Biotechnology; Cancer; Complications and side effects; Gastric cancer; Gene polymorphism; Genetic aspects; Genetic markers; Genetic polymorphisms; Genotype; Genotype & phenotype; Genotypes; Genotyping; Health aspects; Humans; Life Sciences; Lymph nodes; Lymphatic Metastasis; Lymphatic system; Mesothelin; Metastases; Metastasis; Microbial Genetics and Genomics; Microbiology; MicroRNAs - genetics; Mutation; Polymorphism; Polymorphism, Single Nucleotide; Prognosis; Risk; Risk factors; Stomach cancer; Stomach Neoplasms - genetics
• ISSN: 0175-7598; 1432-0614
• DOI: 10.1007/s00253-023-12555-8

Lymph node metastasis, a crucial factor in the spread of gastric cancer (GC), is strongly associated with a negative prognosis for patients. This study aimed to investigate the association of the mesothelin (MSLN) gene polymorphisms (rs3764247, rs3764246, rs12597489, rs1057147, and rs3765319) with the risk of lymph node metastasis of GC patients in a Chinese Han population. The PCR-LDR genotyping was used to detect the genotypes of MSLN polymorphisms in GC patients with lymph node metastasis ( n  = 610) or without ( n  = 356). Our research indicates that certain genetic markers, specifically rs3764247, rs3764246, rs12597489, and rs3765319, do not appear to be linked with an increased risk of lymph node metastasis in GC. However, we did observe that patients with the rs1057147 GA genotype exhibited a higher likelihood of lymph node metastasis in GC when compared to those with the GG genotype (OR = 1.33, 95% CI = 1.01 − 1.76,  P  = 0.045). Patients with rs1057147 GA + AA genotype were found to have a higher likelihood of lymph node involvement (OR = 1.35, 95% CI = 1.03 − 1.77, P  = 0.029) when compared to those with GG genotype in the dominant model. The allelic model revealed that the A allele of rs1057147 exhibited a stronger correlation with lymph node metastasis compared to the G allele (OR = 1.28, 95% CI = 1.02 − 1.60, P  = 0.031). In addition, we found that rs1057147 polymorphism revealed a poor prognosis for GC patients with lymph node metastasis. Further stratified analysis revealed that the prognostic effect of rs1057147 was more pronounced in patients with GC who had lymph node metastasis and had a tumor size of 4 cm or greater, as well as more than 2 lymph node metastases. Bioinformatics studies showed that the binding mode of miR-3144-5p or miR-3619-3p to MSLN was altered by the mutation of rs1057147. Our study confirmed the important role of MSLN rs1057147 polymorphism locus in GC lymph node metastases and suggested a potential prognostic factor during GC progression. Key points • Rs1057147 GA genotype had an increased risk of lymph node metastasis in gastric cancer. • The A allele of rs1057147 had a stronger association with lymph node metastasis than the G allele. • The binding mode of miR-3144-5p or miR-3619-3p to MSLN was altered by the mutation of rs1057147.